In a 26-0 vote, the Senate Finance Committee Nov. 8 reported the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, bipartisan legislation that includes AHA-supported provisions to improve access to behavioral health care and delay Medicaid disproportionate share hospital reductions.

The AHA-supported provisions would provide Medicare incentives to integrate behavioral health and primary care; delay certain Medicaid disproportionate share hospital payment reductions for two years; and permanently grant state Medicaid programs the option to receive federal matching payments for substance use disorder treatment provided in certain institutions for mental diseases. The legislation also would ensure timely communication regarding telehealth and interstate licensure requirements, and extend certain Medicare payment provisions for physicians and clinical laboratory services.

Related News Articles

Headline
The federal government shutdown will continue as the Senate Oct. 3 failed to adopt a government funding deal. The latest attempt to pass the House-passed…
Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…
Perspective
Public
More than 48 million Americans — 16.8% of the 12-and-older population — have a substance use disorder (SUD), according to the 2025 National Survey on Drug Use…
Headline
The AHA Sept. 24 expressed support for the Medical Student Education Authorization Act (H.R. 5428), legislation introduced in the House Sept. 17 that would…
Headline
An AHA blog published Sept. 16 highlights programs and practices by Boston Medical Center leaders and staff that support residents’ mental health, emotional…
Headline
Susan Doherty, AHA’s vice president of field engagement, and Rebecca Chickey, AHA’s senior director of behavioral health services, write on the unique ways…